Legend Capital君联资本的封面图片
Legend Capital君联资本

Legend Capital君联资本

风险投资与私募股权管理人

Beijing,Beijing 6,646 位关注者

Established in 2001, Legend Capital is a leading Venture and Growth capital firm in China.

关于我们

Founded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea.   It currently manages USD and RMB funds of over US$10 billion in commitments, and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors.   Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.

所属行业
风险投资与私募股权管理人
规模
51-200 人
总部
Beijing,Beijing
类型
合营企业
创立
2001
领域
Intellegent Manufacturing and Industy Technology、TMT&Innovative Consumption、Health-care和Supply Chain

地点

  • 主要

    No.2 Kexueyuan South Road, Zhongguancun

    16/F, Tower B, Raycom Info Tech Park

    CN,Beijing,Beijing,100190

    获取路线
  • Room 01A, 17/F, Tower A, East Pacific Intertional, Futian District

    CN,Guang Dong,Shenzhen,518042

    获取路线
  • Office 6113, The Center, 99 Queen's Road Central, Central

    HK,Hong Kong

    获取路线
  • Room 3703 -07, Tower 2, Plaza 66, No. 1266 Nanjing West Road

    CN,Shanghai,Shanghai,200040

    获取路线

Legend Capital君联资本员工

动态

  • #LegendCapital #PortfolioNews Our portfolio company Innovent Biologics’ IBI363, a PD-1/IL-2 bispecific antibody, has entered its first registrational study. Developed to enhance immune responses against less immunogenic tumors, including mucosal and acral melanoma, IBI363 has demonstrated promising efficacy and a manageable safety profile in early trials. This study marks a significant step in evaluating its therapeutic potential and broadening treatment options for melanoma patients. Innovent continues to drive innovation in immunotherapy, advancing new treatment options for challenging cancers. #Oncology #Melanoma

    查看Innovent Biologics的组织主页

    27,173 位关注者

    Innovent's first-in-class PD-1/IL-2 bispecific antibody (R&D: IBI363) has entered its first registrational study—a major breakthrough in the fight against “cold tumors” like mucosal and acral melanoma. With promising efficacy and a manageable safety profile, the trial aims to establish IBI363 as a next-generation immuno-oncology therapy, bringing new hope for patients and potentially transforming treatment outcomes worldwide. https://lnkd.in/gFJ8QSxX #InnoventBiologics #Oncology #melanoma

    • 该图片无替代文字
  • #LegendCapital #PortfolioNews Our portfolio Bespin Global MEA, an e& enterprise company, is driving cloud transformation in the Middle East with a secure, scalable, and future-ready approach. Through its alliance with e& enterprise and AWS, it delivers industry-compliant cloud infrastructure, seamless migration, and end-to-end expertise to accelerate digital transformation in the region. #CloudTransformation #DigitalInnovation 

    We are driving a new era of cloud transformation in the Middle East, making it secure, scalable, and future-ready. The alliance with e& enterprise, AWS, powered by Bespin Global is a commitment to shaping the future of digital transformation with: ✔️ Industry-compliant cloud infrastructure ✔️ Seamless migration & modernization ✔️ End-to-end cloud expertise Download our eBook to discover how this alliance can drive your business forward with cloud innovation. https://bit.ly/3DnZs3S

    • 该图片无替代文字
  • #LegendCapital #PortfolioNews Our portfolio Lunit Cancer Screening has expanded its partnership with Dr. Sulaiman Al Habib Medical Group (HMG), Saudi Arabia’s largest medical organization, to deploy its AI-powered chest X-ray solution, Lunit INSIGHT CXR. This second contract follows the successful implementation of Lunit’s breast cancer screening AI last year and will support the analysis of approximately 1 million chest X-rays over the next three years. Strengthening its presence in the Middle East, Lunit continues to drive AI innovation in medical diagnostics, enhancing efficiency and accuracy in healthcare. #AIHealthcare #MedicalAI #CancerScreening #DigitalHealth #HMG

    查看Lunit Cancer Screening的组织主页

    21,068 位关注者

    🎉 Strengthening Collaboration in Saudi Arabia!  We’re excited to announce that Dr. Sulaiman Al Habib Medical Group (HMG), the largest medical group in Saudi Arabia, has signed a second contract with Lunit to expand the use of our AI to include Lunit INSIGHT CXR, our AI solution for chest X-ray. 👏 This milestone is especially meaningful as #HMG decided to further implement #Lunit AI after experiencing the clinical effectiveness and performance of our breast AI, Lunit INSIGHT MMG, through its initial contract last year. We look forward to continually strengthening our presence in the Middle East, from participating in the Saudi government's SEHA Virtual Hospital project to securing successive contracts with HMG! ✨ ⬇️ Read more #lunitinsight #lunitinsigh #cxr #chestxray #mmg #mommography #cancer #saudiarbia #cancerscreening #cacnerai #medicalai #ai #healthcare #aibusiness #partnership

  • #LegendCapital #PortfolioNews Congratulations to our portfolio company Pharmaron’s Liverpool Biologics & Advanced Therapies CDMO, which has been named Bionow Company of the Year Award at the 2024 Bionow Annual Awards, recognizing its innovation in gene therapies and microbial proteins and its commitment to sustainability. Pharmaron is driving breakthroughs in cutting-edge biologics and advanced therapy capabilities. #Biologics #GeneTherapy #CDMO #HealthcareInnovation

    查看Pharmaron的组织主页

    48,042 位关注者

    We are delighted to announce that 𝐏𝐡𝐚𝐫𝐦𝐚𝐫𝐨𝐧’𝐬 𝐋𝐢𝐯𝐞𝐫𝐩𝐨𝐨𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 & 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐓𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 𝐂𝐃𝐌𝐎 was crowned the winner of the 𝐁𝐢𝐨𝐧𝐨𝐰 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐘𝐞𝐚𝐫 𝐀𝐰𝐚𝐫𝐝 at the 2024 Bionow Annual Awards last night.   The award recognises a leading, globally formidable company who has demonstrated significant progress year on year, whilst also demonstrating notable progress during the past 12 months.  In announcing the winner, the judges recognised our 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐢𝐧𝐠 𝐠𝐞𝐧𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 and expanding our services to microbial proteins, our progress as a business with 92% of existing customers placing new work with us, our commitment to sustainability in achieving the highest MyGreenLabs rating, and our industrial leadership in the sector community especially through supporting and inspiring the next generation of STEM students and apprentices.   The Liverpool team has extensive expertise & a proven track record working across a diverse portfolio of biologics and advanced therapies projects coupled with a long serving technical team committed to building strong, collaborative customer relationships, with a focus on delivering tailored solutions. We are so proud the team have been recognised for their efforts.   Thank you to Bionow, award sponsor Squire Patton Boggs and congratulations to all winners last night. Learn more: https://lnkd.in/dXG-rapn

  • #LegendCapital #PortfolioNews Our portfolio company Bespin Global MEA, an e& enterprise company, is expanding its Microsoft portfolio with a new specialization, reinforcing its expertise in optimizing hybrid and remote work environments. With the Meetings and Meeting Rooms for Microsoft Teams Specialization, Bespin Global MEA continues to enhance seamless and secure virtual collaboration, helping businesses maximize productivity and efficiency. #HybridWork #RemoteWork #MicrosoftTeams #CloudSolutions #DigitalTransformation

    查看Bespin Global MEA, an e& enterprise company的组织主页

    26,070 位关注者

    We’re thrilled to expand our Microsoft portfolio with a new specialization, empowering businesses to enhance hybrid and remote work environments. With the Meetings and Meeting Rooms for Microsoft Teams Specialization, we further solidify our expertise in creating seamless, secure, and efficient virtual collaboration spaces. From optimizing Microsoft Teams to enhancing meeting room setups, Bespin Global is committed to delivering top-tier remote work solutions. Looking to elevate your team's productivity and collaboration? Let’s optimize your hybrid and remote work experience. https://bit.ly/4irO1a3

    • 该图片无替代文字
  • #LegendCapital #PortfolioNews Our portfolio company, WuXi Biologics, has reached a new milestone with the launch of the WuXiaADCC PLUSTM platform, a major advancement in afucosylated antibody production. This next-generation host cell line enhances ADCC effects for improved therapeutic efficacy while streamlining the afucosylation process by eliminating the need for additional treatments. Built on the WuXiaTM CHO-K1 cell line, the platform maintains strong growth and metabolism, achieving an average mAb clone titer of 6 g/L. With stable expression over long-term passages, it enables scalable clinical and commercial manufacturing, reinforcing WuXi Biologics’ leadership in biologics innovation. #Biotech #Innovation #WuXiBiologics #ADCC

    查看WuXi Biologics/药明生物的组织主页

    103,585 位关注者

    Exciting News! WuXi Biologics just launched the WuXiaADCC PLUS™ platform, a novel development in afucosylated antibody production. We've created a host cell line that enhances ADCC effects, improving therapeutic efficacy, while simplifies the afucosylation process, eliminating the need for laborious treatments. Based on the WuXia™ CHO-K1 cell line, it maintains robust growth and metabolism, boasting an impressive average mAb clone titer of 6 g/L. This breakthrough ensures stable expression over long-term passages, facilitating scalable clinical and commercial manufacturing. Ready to elevate your cell line development? Explore the potential with WuXiaADCC PLUS™: https://lnkd.in/efexPBhp #Biotech #Innovation #WuXiBiologics #ADCC #AntibodyProduction#cell line development

    • 该图片无替代文字
  • #LegendCapital #PortfolioNews One of our portfolio companies, Bespin Global MEA, an e& enterprise company, has reached a new milestone as a certified AWS Lambda Delivery Partner, further strengthening its expertise in AWS cloud solutions. This recognition highlights the company’s deep capabilities in serverless computing and its commitment to delivering scalable, cost-efficient solutions. With AWS Lambda, businesses can run code without provisioning or managing servers, ensuring seamless scaling and optimized performance. As a trusted AWS partner, Bespin Global empowers organizations to harness the full potential of serverless architecture—enhancing agility, reducing costs, and driving innovation. #Innovation #AWS #Solution

    We're excited to expand our AWS cloud expertise with another powerful specialization—proudly joining the ranks as a certified AWS Lambda Delivery Partner! In today’s fast-moving market, businesses need solutions that scale effortlessly and adapt quickly without driving up costs. AWS Lambda delivers exactly that, enabling organizations to run code without provisioning servers—automatically scaling applications to meet demand. As an AWS Lambda Delivery Partner, Bespin Global is here to help businesses unlock the full potential of serverless architecture—driving cost efficiency, agility, and innovation. Ready to get started? Connect with our experts today: https://bit.ly/4bsklaL

    • 该图片无替代文字
  • #LegendCapital #PortfolioAwards Congratulations to our portfolio company Milkyway Chemical Logistics on receiving the 2024 Best Logistics Award from Jiangsu Nata Opto-electronic Materials Co., Ltd. Milkyway is a leading Chemical Supply Chain service provider and offers comprehensive logistics solutions. This award has further recognized Milkyway’s outstanding performance in logistics solutions and its commitment to providing trustful services for their customers. Congratulations to the team! #Logistics #SupplyChain

    查看Milkyway Chemical Logistics的组织主页

    7,480 位关注者

    🎉 Milkyway Wins 2024 Best Logistics Award from Nata Opto-electronics! 🎉 We are honored to receive the 2024 Best Logistics Award from Jiangsu Nata Opto-electronic Materials Co., Ltd., a leading company in China’s high-purity electronic materials industry. This award is a testament to our customers’ trust and recognition of Milkyway’s logistics services. Looking ahead, we remain committed to solving logistics challenges for hazardous chemicals in the semiconductor, new energy, and advanced materials industries, ensuring safe and efficient supply chain solutions. Thank you to Nata Opto-electronics for this recognition—we look forward to continuing our partnership! #Milkyway #LogisticsExcellence #SupplyChainSolutions #HazardousGoods #Semiconductors #NewEnergy #ChemicalLogistics

    • 该图片无替代文字
  • #LegendCapital With International Women's Day just around the corner, Legend Capital君联资本 extends heartfelt appreciation to all the remarkable women across our team, portfolio companies, and partners. Your dedication, talent, and resilience are invaluable to everything we strive to achieve. On this special day, we celebrate you—may you always #BeHappy and #BeStrong in the workplace and beyond. Happy International Women’s Day! #IWD #InternationalWomensDay #WomenInBusiness #Diversity #Sustainability #ESG

    • 该图片无替代文字
  • #LegendCapital #PortfolioNews Hanshow and Woolworths Group have been recognized with RETA Awards for their collaboration on the Scan & Go Trolley, with Woolworths recognized for the Artificial Intelligence category, and Hanshow named as a Top Retail Supplier at EuroCIS 2025. This innovative solution, powered by Hanshow’s Smart Cart technology, enables real-time budget tracking, seamless self-checkout, and enhanced shopping convenience. By integrating intelligent sensors, NFC payment, and a built-in scanner, the system improves operational efficiency while redefining the in-store experience. Currently in trial across 10 Woolworths supermarkets, it represents a major step toward smarter, more customer-centric retail solutions. #RetailInnovation #SmartCart #RetailTech #EuroCIS #EHIRetailInstitue

    🏆 We are thrilled to congratulate Woolworths Group for being awarded EHI Retail Institute RETA Awards for Artificial Intelligence at EuroCIS - The Leading Trade Fair for Retail Technology!   🔹 🛒✨With the Scan&Go Trolley, Woolworths is transforming retail with real-time budget tracking, AI-powered scanning, and seamless checkout—delivering unmatched convenience and efficiency. 🔹 ⏳💰Integrating Hanshow’s Smart Cart Solution with Woolworths Scan&Go platform, the Scan&Go Trolley is a market-leading innovation that helps customers save time and balance their budget. As a proud partner, Hanshow was also awarded the Reta Awards for Top Retail Supplier, 2025.

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字

相似主页